Longevity of SLE-prone mice increased by dietary 2-mercaptoethanol via a mechanism imprinted within the first 28 days of life

References

• Click RE, Benck L, Alter BJ. Enhancement of antibody synthesis in vitro by mercaptoethanol. Cell Immunol 1972; 3:156 - 160
   PubMedGoogle Scholar
• Click RE, Benck L, Alter BJ. Immune responses in vitro. (I) Culture conditions for antibody synthesis. Cell Immunol 1972; 3:264 - 276
   PubMed Web of Science ®Google Scholar
• Heber-Katz E, Click RE. Immune responses in vitro. (V) Role of mercaptoethanol in the mixed-leukocyte reaction. Cell Immunol 1972; 3:410 - 418
   Web of Science ®Google Scholar
• Katz-Heber E, Peck AB, Click RE. Immune responses in vitro. (II) Mixed leukocyte interaction in a protein-free medium. Eur J Immunol 1973; 3:379 - 385
   PubMed Web of Science ®Google Scholar
• Peck AB, Click RE. Immune responses in vitro. (III) Enhancement of the mouse mixed lymphocyte interaction by isologous and homologous sera. Eur J Immunol 1973; 3:385 - 392
   PubMed Web of Science ®Google Scholar
• Peck AB, Katz-Heber E, Click RE. Immune response in vitro. (IV) Comparison of mouse mixed lymphocyte interactions in protein-free culture medium and in medium supplemented with isologous serum. Eur J Immunol 1973; 3:516 - 519
   PubMed Web of Science ®Google Scholar
• Click RE. Obesity, longevity, quality of life: Alteration by dietary 2-mercaptoethanol. Virulence 2010; 1:512 - 518
   Google Scholar
• White K, Bruckner JV, Guess WL. Toxicological studies of 2-mercaptoethanol. J Pharm Sci 1973; 62:237 - 241
   PubMed Web of Science ®Google Scholar
• Chang MP, Tamaka JL, Stosic-Grujicic S, Yamamoto EK, Perkins EH, Strehier BL, et al. Restoration of impaired immune functions in aging animals. (VI) Differential potentiating effect of 2-mercaptoethanl on young and old murine spleen cells. Int J Immunopharmacol 1982; 4:429 - 436
   PubMed Web of Science ®Google Scholar
• Heidrick ML, Hendricks LC, Cook DE. Effect of dietary 2-mercaptoethanl on the life span, immune system, tumor incidence and lipid peroxidation damage in spleen lymphocytes of aging BC3F1 mice. Mech Ageing Dev 1984; 31:341 - 356
   Web of Science ®Google Scholar
• Beregi E, Regius O, Rajczy K, Boross M, Penzes L. Effect of cigarette smoke and 2-mercaptoethanol administration on age-related alterations and immunological parameters. Gerontology 1991; 37:326 - 334
   PubMed Web of Science ®Google Scholar
• Fischer HD, Wustmann C, Rudolph E, Oehler J, Jahkel M, Rostock A, et al. Effect of 2-mercaptoethaol on posthypoxic and age related biochemical and behavioral changes in mice and rats. Biomed Biochim Acta 1990; 49:1085 - 1090
   PubMedGoogle Scholar
• Altman A, Theofilopoulos AN, Weiner R, Katz DH, Dixon FJ. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med 1981; 154:791 - 808
   PubMed Web of Science ®Google Scholar
• Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148:1198 - 1215
   PubMed Web of Science ®Google Scholar
• Foster MH. Relevance of systemic lupus erythematosus nephritis animal models to human disease. Semin Nephrol 1999; 19:12 - 24
   PubMed Web of Science ®Google Scholar
• Reichin M, Harley JB, Lockshin MD. Serologic studies of monozygotic twins with systemic lupus erythematosus. Arthritis Rheum 1992; 35:457 - 464
   PubMed Web of Science ®Google Scholar
• Santiago-Raber ML, Laporte C, Reininger L, Izui S. Genetic basis of murine lupus. Autoimmunity Rev 2004; 3:33 - 39
   PubMed Web of Science ®Google Scholar
• Gatev V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL 10 as risk loci for systemic lupus erythematosus. Nature Genetics 2009; 41:1228 - 1233
   PubMed Web of Science ®Google Scholar
• Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nature Genetics 2009; 41:1234 - 1237
   PubMed Web of Science ®Google Scholar
• Bagavant H, Fu SM. New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells. Curr Opin Rheumatol 2005; 17:523 - 529
   PubMed Web of Science ®Google Scholar
• Bagavant H, Fu SM. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol 2009; 21:489 - 494
   PubMed Web of Science ®Google Scholar
• Fujii T, Okada M, Fujita Y, Sato T, Tanaka M, Usui T, et al. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice. Autoimmun 2009; 33:125 - 134
   Web of Science ®Google Scholar
• Greeley SAW, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, et al. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 2002; 8:399 - 402
   PubMed Web of Science ®Google Scholar
• Bao L, Haas M, Kraus DM, Hack BK, Rakstang JK, Holers VM, et al. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. J Am Soc Nephrol 2003; 14:670 - 679
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci 2010; 107:12204 - 12209
   PubMed Web of Science ®Google Scholar
• Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci 2010; In press
   Web of Science ®Google Scholar
• Barrat FJ, Meeker T, Chan JH, Guiducci C, Coffman RL. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol 2007; 37:3582 - 3586
   PubMed Web of Science ®Google Scholar
• Santiago-Raber ML, Baudino L, Izui S. Emerging roles of TLR7 and TLR9 in murine SLE. J Autoimmunity 2009; 33:231 - 238
   PubMed Web of Science ®Google Scholar
• Manicassamy S, Ravindran R, Deng J, Oluoch H, Denning TL, Kasturi SP, et al. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med 2009; 15:401 - 409
   PubMed Web of Science ®Google Scholar
• Hayashi T, Gray CS, Chan M, Tawatao RI, Ronacher L, McGargill MA, et al. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7. Proc Natl Acad Sci USA 2009; 106:2764 - 2769
   PubMed Web of Science ®Google Scholar
• Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci 2010; 107:11942 - 11947
   PubMed Web of Science ®Google Scholar
• Chen C, Hirsch JG. Restoration of antibody-forming capacity in cultures of nonadherent spleen cells by mercaptoethanol. Science 1972; 176:60 - 61
   PubMed Web of Science ®Google Scholar
• Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferonalpha-producing antigen-presenting cells. Arthritis Rheum 2008; 58:801 - 812
   PubMed Web of Science ®Google Scholar
• Jensen SS, Gad M. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-cytokine based cocktails: targeting dendritic cells in autoimmunity. J Inflam 2010; 7:37 - 49
   Google Scholar
• Pulendran B, Tang H, Manicassamy S. Programming dendritic cells to induce TH2 and tolerogenic responses. Nature Immun 2010; 11:647 - 655
   PubMed Web of Science ®Google Scholar
• Monrad SU, Desch KC, Kaplan MJ. Role of Dendritic dells in the pathogenesis of systemic lupus erythematosus. Future Rheumatol 2008; 3:269 - 279
   Google Scholar
• Wu HY, Staines NA. A deficiency of CD4+,CD25+ T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus 2004; 13:192 - 200
   PubMed Web of Science ®Google Scholar
• Kang HK, Datta SK. Regulatory T cells in lupus. Int Rev Immunol 2006; 25:5 - 25
   PubMed Web of Science ®Google Scholar
• Humrich JY, Morbach H, Undeutsch R, Enghard P, Rosenberger S, Weigert O, et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc Natl Acad Sci 2010; 107:204 - 209
   PubMed Web of Science ®Google Scholar
• Benkhoucha M, Santiago-Raber ML, Schneiter G, Chofflon M, Funakoshi H, Nakamura T, et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 2010; 107:6424 - 6429
   PubMed Web of Science ®Google Scholar
• Casciola Rosen LA, Miller DK, Anhalt GJ, Rosen A. Specific cleavage of the 70 kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994; 269:30757 - 30760
   PubMed Web of Science ®Google Scholar
• Casciola Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996; 183:1957 - 1964
   PubMed Web of Science ®Google Scholar
• Casiano CA, Martin SJ, Green DR, Tan EM. Selective cleavage of nuclear auto-antigens during CD95 (Fas/Apo-19)-mediated T cell apoptosis. J Exp Med 1996; 184:765 - 770
   PubMed Web of Science ®Google Scholar
• Deng H, Apple R, Clare-Salzler M, Trembleau S, Mathis D, Adorini L, et al. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med 1993; 178:1675 - 1680
   PubMed Web of Science ®Google Scholar
• Yoshiki T, Mellors RC, Strand M, August JT. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 1974; 140:1011 - 1027
   PubMed Web of Science ®Google Scholar
• Karim MY, Pisoni CN, Khamashta MA. Update on immunotherapy for Systemic lupus erythematosus—What's hot and what's not. Rheum 2009; 48:332 - 341
   Web of Science ®Google Scholar
• Monneaux F, Muller S. Molecular therapies for systemic lupus erythematosus: Clinical trials and future prospects. Arthritis Res Ther 2009; 11:234 - 244
   PubMed Web of Science ®Google Scholar
• Crow MK. Developments in the clinical understanding of lupus. Arthritis Res Ther 2009; 11:245 - 256
   PubMed Web of Science ®Google Scholar
• Delaleu N, Peck AB. Autoimmunity: limited progress for the patient, despite decades of research. Scand J Immunol 2009; 70:411 - 414
   PubMed Web of Science ®Google Scholar
• Sun L, Aklyama K, Zhang H, Yamaza T, Hou Y, Zhao S, et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009; 27:1421 - 1432
   PubMed Web of Science ®Google Scholar
• Ikehara S. The future of stem cell transplantation in autoimmune disease. Clin Rev Allergy Immunol 2009; 38:292 - 297
   Web of Science ®Google Scholar
• Halade GV, Rahman MM, Bhattacharya A, Barnes JL, Chandrasekar B, Fernandes G. Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupusprone mice. J Immunol 2010; 184:5280 - 5286
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, et al. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1. mice. J Immunol 2003; 170:5793 - 5798
   PubMed Web of Science ®Google Scholar
• Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferongamma-receptor inhibits the onset of glomerulonephritis. Eur J Immunol 1995; 25:6 - 12
   PubMed Web of Science ®Google Scholar
• Bolland S, Yim YS, Tus K, Wakeland EK, Ravetch JV. Genetic modifiers of systemic lupus erythematosus in FcγRIIB-/- mice. J Exp Med 2002; 195:1167 - 1174
   PubMed Web of Science ®Google Scholar
• Merino R, Iwamoto M, Fossati L, Muniesa P, Araki K, Takahashi S. Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-Eα chain. J Exp Med 1993; 178:1189 - 1197
   PubMed Web of Science ®Google Scholar
• Coca A, Sanz I. B cell depletion in lupus and Sjogren's Syndrome: An update. Curr Opin Rheumatol 2009; 21:483 - 488
   PubMed Web of Science ®Google Scholar
• Favas C, Isenberg DA. B-cell-depletion therapy in SLE—what are the current prospects for its acceptance?. Nat Rev Rheumatol 2009; 5:711 - 716
   PubMed Web of Science ®Google Scholar
• Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, et al. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 1994; 93:1029 - 1034
   PubMed Web of Science ®Google Scholar